2017
DOI: 10.14295/bds.2017.v20i3.1362
|View full text |Cite
|
Sign up to set email alerts
|

Surgical treatment of osteonecrosis associated with bisphosphonates: a case report

Abstract: <p>Bisphosphonates (BP) are routinely used in the management of metastatic bone diseases and malignancies neoplasms, but there is an adverse effect of their chronic use called bisphosphonate-related osteonecrosis of the jaw (BRONJ). Treatment for BRONJ is challenging and complex, as there is still no definitive treatment protocols and the various treatments described in the literature have success variables indexes. In this sense, this study aims to emphasize the responsibility of dentist about the knowl… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 19 publications
(32 reference statements)
0
1
0
Order By: Relevance
“…In addition to bisphosphonates, alendronate, zoledronate, and other drugs such as denosumab and antiangiogenics are related to osteonecrosis of the jaw [8]. For preventing, diagnosing, and treating this disease in the most appropriate manner, it is essential that dentists possess knowledge about this pathology [9].…”
Section: Introductionmentioning
confidence: 99%
“…In addition to bisphosphonates, alendronate, zoledronate, and other drugs such as denosumab and antiangiogenics are related to osteonecrosis of the jaw [8]. For preventing, diagnosing, and treating this disease in the most appropriate manner, it is essential that dentists possess knowledge about this pathology [9].…”
Section: Introductionmentioning
confidence: 99%